# VIVJOA
> **NDA215888** · New Drug Application · Sponsor: MYCOVIA PHARMS · Approved 2022-04-26
## Drug
- **FDA Application Number:** NDA215888
- **Application type:** New Drug Application
- **Brand name:** VIVJOA
- **Generic name:** OTESECONAZOLE
- **Active ingredients:** OTESECONAZOLE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MYCOVIA PHARMS
- **Manufacturer:** Mycovia Pharmaceuticals, Inc.
- **First approval:** 2022-04-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215888)
---
*MORVS · CC0 1.0*